Quaero Life Science
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A clinical-stage biotech developing innovative small molecule drugs for oncology and immunology indications.
OncologyImmunology
Technology Platform
A discovery platform targeting hard-to-drug intracellular proteins using structure-based design and advanced medicinal chemistry.
Opportunities
Generating compelling mid-stage clinical data to attract global pharmaceutical partnership deals or position for an IPO.
Risk Factors
Clinical failure of its lead assets, which are still in mid-stage trials, could significantly impact valuation and funding prospects.
Competitive Landscape
Operates in the crowded but high-potential field of targeted oncology and immunology, competing on novel mechanism and clinical proof-of-concept.